Sarveshwar Foods board meet Sep 2026: fund raise, ESOP

What the company has announced

Sarveshwar Foods Limited has scheduled a meeting of its Board of Directors for September 5, 2026. The key agenda items include evaluating proposals to raise funds through equity shares or convertible instruments and considering the adoption of the company’s Employee Stock Option Scheme 2026.

The fundraising plan, as outlined, is broad and includes multiple possible routes that are commonly used by listed companies to raise capital. Separately, the ESOP proposal is positioned as a structured scheme that will require adherence to SEBI’s share-based benefit rules and shareholder approval.

Board meeting on September 5, 2026: two core agenda items

The board will deliberate on two primary items. First is fundraising through the issuance of equity shares, convertible instruments, or other securities. The company indicated that the issuance could be done through mechanisms such as preferential allotment, rights issue, QIP, ADRs, GDRs, or FCCBs.

Second is the introduction of the Sarveshwar Foods Limited Employee Stock Option Scheme 2026. The company stated the ESOP will be in accordance with SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021 and other applicable laws, and will be subject to recommendations of the Nomination and Remuneration Committee along with shareholder approval.

Fundraising options under consideration

Sarveshwar Foods has kept multiple fundraising instruments on the table, ranging from domestic equity issuance to overseas capital-market options. The list includes equity shares, convertible instruments, and other securities, with potential issuance methods specifically including preferential allotment and rights issue, as well as institutional placements such as QIP.

On the overseas side, the company has listed ADRs, GDRs, and FCCBs as possible routes. These options typically come with additional compliance requirements and are more relevant when a company intends to access non-domestic investor pools.

The company’s agenda language suggests that the board meeting is intended to evaluate proposals rather than announce a final structure immediately. Specific terms, pricing, or timelines for any fresh issuance were not provided in the shared details.

ESOP Scheme 2026: what is being proposed

The second agenda item is the adoption of “Sarveshwar Foods Limited Employee Stock Option Scheme 2026.” The company has stated the scheme will be aligned with SEBI’s 2021 regulations governing share-based employee benefits and sweat equity.

The adoption is also subject to the recommendation of the Nomination and Remuneration Committee and the approval of shareholders. This indicates that even if the board considers and approves the framework, the proposal is expected to move through the company’s governance process before it becomes effective.

Warrant conversions: recent equity allotments in January 2026

Alongside the upcoming board agenda, Sarveshwar Foods has already undertaken equity allotments through warrant conversions in January 2026. One disclosure in the provided material states the company sanctioned the issuance of 3,750,000 equity shares (face value Re 1 each) at a price of ₹9.70 per share, following conversion of an equivalent number of warrants issued on a preferential basis.

A separate set of details highlights another warrant conversion that resulted in the issuance of 2,00,000 equity shares (face value ₹1) at ₹9.70 per share. It states ₹14.55 lakh (0.1455 crore) was received, representing 75% of the warrant price payable at conversion, and that board approval was granted through a circular resolution dated January 21, 2026.

The text also notes that the 2,00,000-share conversion was done by Mr. Rajat Mengi, and that the allotment was approved by the board via circular resolution.

The July 2024 preferential warrant allotment: size and structure

The underlying warrants were originally allotted on July 25, 2024. The provided information states the company allotted 10,20,00,000 fully convertible warrants on a preferential basis to persons belonging to the “Non-Promoter, Public Category” at an issue price of ₹9.70 per warrant.

Each warrant carries the right to subscribe to one equity share of face value Re 1 per warrant. The conversion window is stated as within 18 months from the allotment date. The structure also includes a split payment mechanism: 25% of the issue price is paid upfront at the time of subscription, with the balance 75% payable at the time of conversion.

The warrants are described as being subject to shareholder approval and necessary regulatory clearances, and are also subject to a lock-in period.

Money raised and amounts cited in disclosures

The company’s disclosures include multiple cash-flow figures linked to the warrant programme. One disclosure states that for the warrant allotment, 25% of the allotment amounting to ₹24,73,50,000 (₹24.735 crore) was received on the date of allotment.

Another line states the company plans to raise ₹9,894 lakhs (₹98.94 crore) for long-term growth by issuing 10,20,00,000 warrants at ₹9.70 per warrant. Separately, the material also mentions the company’s intention to raise an additional ₹100 crore through methods including QIP, ADRs, GDRs, FCCBs, or other legal methods or combinations.

It also indicates fundraising could be done in multiple tranches, with each tranche having a maximum size of ₹50 crore, and that the final terms would be set by the board in compliance with the Companies Act, 2013 and relevant SEBI regulations.

What this means for capital structure and dilution

The repeated use of preferential warrants and subsequent conversions indicates that Sarveshwar Foods has been using equity-linked instruments as a capital-raising route. Warrant conversion leads to new equity issuance, which can expand the share base.

From an investor perspective, the key consideration is how much additional equity gets issued over time and how future fundraising, if approved, is structured. The company’s board agenda for September 5, 2026 is important because it explicitly contemplates further issuance of equity shares or convertible instruments, which could again affect the capital structure.

At the same time, the company has also put forward an ESOP scheme, which is another mechanism that can create equity-linked allocations over time, subject to the scheme design and shareholder approvals.

Key facts at a glance

What investors will track next

The immediate next trigger is the outcome of the board meeting scheduled for September 5, 2026. Investors typically watch whether the board merely evaluates options or formally approves a specific issuance route, including the size, pricing framework, and timeline.

For the ESOP, the next steps indicated include consideration by the Nomination and Remuneration Committee and shareholder approval. On fundraising, investors will also track whether the company proceeds via a domestic issuance like preferential allotment or QIP, or explores overseas instruments like ADRs, GDRs, or FCCBs.

Conclusion

Sarveshwar Foods has set September 5, 2026 as the date for a board meeting focused on two decisions: evaluating equity-linked fundraising proposals and adopting an ESOP framework under SEBI’s 2021 regulations. The meeting comes against the backdrop of a continuing warrant programme approved in July 2024 and subsequent warrant conversions and equity allotments reported in January 2026.

The next confirmed milestone is the board’s decision on September 5, 2026, followed by any required shareholder approvals for the ESOP and for any capital-raising route that requires shareholder consent under applicable rules.